In-depth proteomic analysis of proteasome inhibitors bortezomib, carfilzomib and MG132 reveals that mortality factor 4-like 1 (MORF4L1) protein ubiquitylation is negatively impacted

标题
In-depth proteomic analysis of proteasome inhibitors bortezomib, carfilzomib and MG132 reveals that mortality factor 4-like 1 (MORF4L1) protein ubiquitylation is negatively impacted
作者
关键词
Ubiquitin, Proteasome inhibitor, GlyGly sites, NEM, Statistics, MORF4L1
出版物
Journal of Proteomics
Volume 241, Issue -, Pages 104197
出版商
Elsevier BV
发表日期
2021-04-14
DOI
10.1016/j.jprot.2021.104197

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started